Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues - - Astellas to lead commercialization of VIR-5500 in the U.S. with Vir ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Vir Biotechnology (NASDAQ:VIR) used its latest investor call to outline a new strategic collaboration with Astellas to advance VIR-5500, a PSMA-directed, dual-masked T-cell engager for prostate cancer ...
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...
Vir Biotechnology, Inc. ( VIR) Q4 2025 Earnings Call February 23, 2026 5:30 PM EST ...
Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS ...
24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested ...
Mediafeed on MSN
Does testosterone cream really work?
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Testosterone cream is a needle-free testosterone therapy ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:50 AM ESTCompany ParticipantsLarry Wood - President, ...
There’s growing concern that the US Department of Health and Human Services is abandoning the US Preventive Services Task ...
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results